(Q48706070)

English

Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study.

scientific article published on 20 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

quality of life

1 reference

based on heuristic

inferred from title

author name string

B Biesma

1

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

A N M Wymenga

2

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

A Vincent

3

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

O Dalesio

4

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

H J M Smit

5

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

J A Stigt

6

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

E F Smit

7

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

C L van Felius

8

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

J W G van Putten

9

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

J P J Slaets

10

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

H J M Groen

11

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

Dutch Chest Physician Study Group

12

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

publication date

20 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

22

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

7

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

1520-1527

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the eld

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Vulnerability in the elderly: frailty

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

The timed "Up & Go": a test of basic functional mobility for frail elderly persons

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Development and validation of brief measures of positive and negative affect: The PANAS scales

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Early change in patient-reported health during lung cancer chemotherapy predicts clinical outcomes beyond those predicted by baseline report: results from Eastern Cooperative Oncology Group Study 5592.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ637

21 January 2018

Identifiers

10.1093/ANNONC/MDQ637

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 February 2018

http://europepmc.org/abstract/MED/21252061

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48706070&oldid=1479304282"